Sign In
19 Nov 2008 10:30
Byotrol plc
("Byotrol" or the "Company")
Result of General Meeting
Directors' Shareholdings
The Board of Byotrol, the AIM-quoted anti-microbial technology company, is pleased to announce that all the resolutions relating to the placing of 36,363,636 new ordinary shares by Charles Stanley Securities to raise GBP4.0 million were duly passed at the General Meeting held earlier today.
Application has been made for 36,363,636 new ordinary shares to be admitted to trading on AIM. Admission is expected on 20 November 2008.
Upon Admission, the total number of issued shares in the Company will be 83,716,411.
David McRobbie and Stephen Falder have subscribed for 227,273 new ordinary shares each in the placing. Therefore, the interests of the Directors (and their immediate families and or persons connected with them) in the issued share capital of the Company following admission will be as follows:
|
Name
|
Shareholding
|
|
|
|
Number of Ordinary Shares
|
%
|
|
Wesley Devoto
|
509,040
|
0.61
|
|
David McRobbie
|
4,174,887
|
4.99
|
|
Stephen Falder
|
5,285,854
|
6.31
|
|
Richard Bell
|
20,000
|
0.02
|
|
Ian Mainman
|
363,600
|
0.43
|
|
Adrian Smith
|
-
|
-
|
19 November 2008
Contact:
|
Byotrol plc |
|
|
David McRobbie, Chief Executive Officer Richard Bell, Finance Director |
Tel 0161 277 9518 |
|
Charles Stanley Securities (Nominated Adviser & Broker) |
|
|
Philip Davies / Rick Thompson / Carl Holmes |
Tel 020 7149 6000 |
Follow the stocks
